Retatrutide (LY3437943) agonist hormone receptor 3 (triple-hormone receptor agonist tri-agonist) the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon obesity phase 2, double-blind, randomized, placebo-controlled trial retatrutide obesity recruit BMI 30 or BMI 27-30 at least one weight-related condition 48 retatrutide 12 mg 5%, 10% 15% 100%, 93% 83% obesity nejm.org/doi/full/10.1056/NEJMoa2301972 Attachments retatrutide ( 322 kB ) 2292
Weve seen that many individuals struggle with food noise or a constant preoccupation with eating
Sterile techniques to prevent infection
Similar to IV therapy in terms of direct delivery into the bloodstream, these injections are typically administered intramuscularly or subcutaneously, depending on the treatment plan
However, this effect was observed at doses that were several times higher than the MIC values